Stay updated on Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial
Sign up to get notified when there's something new on the Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial page.

Latest updates to the Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial page
- Check3 days agoChange DetectedFooter revision label updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedAdded Revision: v3.5.0; Removed Revision: v3.4.3.SummaryDifference0.0%

- Check39 days agoChange DetectedSite revision updated to v3.4.3, replacing the prior Revision: v3.4.2.SummaryDifference0.0%

- Check68 days agoChange DetectedFooter now displays Revision: v3.4.2 and the older government funding/operating status notices (v3.4.1) have been removed.SummaryDifference0.4%

- Check75 days agoChange DetectedNotice about a lapse in government funding and the NIH Clinical Center's operating status added; site revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check82 days agoChange DetectedUI and metadata updates include a glossary toggle, a new label 'Last Update Submitted that Met QC Criteria' for QC status, capitalization changes for 'No FEAR Act Data', and a new page revision indicator 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial page.